ClinicalTrials.Veeva

Menu

Changes of Optical Quality During the Peak of the Covid-19 Pandemic

T

Tianjin Eye Hospital

Status

Completed

Conditions

Corneal Wavefront Aberration
SARS-CoV-2

Study type

Observational

Funder types

Other

Identifiers

NCT05882383
KY-2023019

Details and patient eligibility

About

To explore whether cornea structure, and optical quality are affected by the covid-19 infection.

Full description

Participants with healthy corneas admitted to Tianjin Eye Hospital from November 25 to January 20, 2022 were followed up . At the end of the follow-up, the investigators recorded in detail whether the patients had undergone real-time reverse transcriptase polymerase chain reaction (covid-19 RT-PCR tests) testing, testing time and results. The presence of PCR-positive during follow-up is considered to be covid-19 infection; PCR-Negative and no symptoms of infection during the follow-up period are considered not infected; participants with symptoms but no PCR test were excluded from the study.Participants were divided into three groups according to the RT-PCR results and the presence or absence of symptoms of infection during follow-up. pentacam (Pentacam HR, Oculus, Wetzlar, Germany) was performed during follow-up and the results were recorded,and the data was statistically managed and compared.

Enrollment

110 patients

Sex

All

Ages

18 to 32 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Included Criteria

  1. Best corrected visual acuity (BCVA) ≥ 20/20;
  2. No other eye diseases except myopia and astigmatism;
  3. The cornea was transparent, and there was no cloud or pannus;
  4. No clinical manifestation of Eye disease or systemic disease;

Exclusion Criteria:

  1. corneal disease;
  2. ocular trauma;
  3. Pregnant and lactating women;

Trial design

110 participants in 3 patient groups

Control Group
Description:
unifected with SARS-CoV-2 during follow-up
Group A
Description:
uninfected at the first visit, have been infected at the second visit
group B
Description:
have been infected at twice visit

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems